Will US Doctors Prescribe Biosimilars?
I
InCrowd
12 min read ยท Apr 15, 2026
An InCrowd Syndicated Report on biosimilars adoption in the US. You'll learn about physician and pharmacist attitudes, perceptions, and expectations around the onset of biosimilars in the US. Get the key takeaways from a 6-minute microsurvey of this group of healthcare stakeholders.
Access Full Briefing
This research is reserved for our professional network. Enter your work details below to access the full PDF report.